viewTexas Instruments

Texas Instruments misses on revenue, offers weak 4Q guidance; analysts weigh in on what it means for chip sector

The semiconductor company saw strong performance in the industrial and automotive markets but slashed its fourth-quarter outlook

Texas Instruments logo on a building
Texas Instruments may be best known for its high-tech calculators

Texas Instruments Inc (NASDAQ:TXN) shares sank after the company fell short on revenue in its third-quarter results while its fourth-quarter outlook missed guidance.

The tech company reported earnings of $1.58 per share on revenue of $4.26 billion compared with $1.26 EPS on revenue of $4.12 billion in the previous year’s third quarter.

READ: Texas Instruments shares jump after dividend increase and US$12bn stock buyback

The Texas-based company beat Wall Street estimates of $1.53 EPS, but fell below revenue expectations of $4.3 billion.

Shares were down in Tuesday after-hours trading and continued falling nearly 6% to S94.30 in Wednesday pre-market trading.

Analog revenue grew 8 percent while its Embedded Processing segment declined 4 percent compared with the previous third quarter.

The semiconductor company is perhaps best known for its high-tech calculators, but also performed well in the industrial and automotive markets.

Texas Instruments’ outlook for the fourth quarter came in below analyst estimates.

The company is expecting earnings per share between $1.14 and $1.34 on revenue of $3.60 billion to $3.90 billion versus analyst consensus of $1.38 EPS on revenue of $4 billion.

Texas Instruments recently raised its dividend by 24% to $0.77 per share from $0.62 per share, payable November 19 to shareholders of record on October 31.

Its board also authorized a stock buyback of $12 billion worth of shares on top of previously announced $7.4 billion repurchase program.

Two analysts weigh in

Baird analyst Tristan Gerra doesn’t think the semiconductor space is heading into a major downturn just yet.

Gerra is maintaining a Neutral rating on Texas Instruments’ shares with a price target of $115, citing the continued strength of the company’s semi fundamentals and its growth in the industrial and automotive markets.

“Traditional cycle measures such as lead times, distributor inventories and pricing show relative stability. Industrial has historically been the most lagging end-market for semis when entering a downturn,” wrote Gerra.

The analyst forecast that these factors would lead to a near-term inventory correction followed by a stabilization in order trends.

Oppenheimer analyst Rick Schafer maintained an Outperform rating but lowered the price target to $120 from $130.

The analyst viewed Texas Instruments’ fourth-quarter outlook slash as the first sign of an early-stage semiconductor cycle correction, highlighting the company’s diversified industrial and auto business model and strong management team.

Despite the slowdown in the semis, Schafer said that Oppenheimer remains long-term buyers.

“TXN remains the swiss watch of capital allocation, committed to returning 100% of FCF [free cash flow] to shareholders,” wrote Schafer.


Contact Lenore Fedow at [email protected]

Follow her on Twitter@LenoreMariee

Quick facts: Texas Instruments

Price: 131.66 USD

Market: NYSE
Market Cap: $123.07 billion

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events


The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...



Full interview: Lexaria Bioscience and Cannadips CEO’s discuss key point of...

Lexaria BioScience (OTC: LXRP-CSE: LXX) CEO Chris Bunka and Case Mandel, CEO of Cannadips joined Steve Darling from Proactive Vancouver on Skype with news the company has signed a licensing deal for their DehydraTech technology with Cannadips from Humboldt, California. Bunka telling Proactive...

6 hours, 11 minutes ago

3 min read